Citation: | Luo GX,Li HS,Yuan ZQ,et al.No administering prophylactic systemic antibiotics routinely during the shock phase after burn injury[J].Chin J Burns Wounds,2024,40(10):911-914.DOI: 10.3760/cma.j.cn501225-20240809-00300. |
[1] |
LiH, ZhouJ, PengY, et al. The progress of Chinese burn medicine from the Third Military Medical University-in memory of its pioneer, Professor Li Ao[J/OL]. Burns Trauma, 2017,5:16[2024-08-09]. https://pubmed.ncbi.nlm.nih.gov/28573147/. DOI: 10.1186/s41038-017-0082-z.
|
[2] |
JeschkeMG, van BaarME, ChoudhryMA, et al. Burn injury[J]. Nat Rev Dis Primers, 2020,6(1):11. DOI: 10.1038/s41572-020-0145-5.
|
[3] |
KhalafF, RicciutiZ, BarayanD, et al. Post-burn endocrine-immune dynamics and ageing considerations[J]. Nat Rev Endocrinol, 2024,20(10):567-568. DOI: 10.1038/s41574-024-01018-3.
|
[4] |
OsukaA, ShigenoA, MatsuuraH, et al. Systemic immune response of burns from the acute to chronic phase[J]. Acute Med Surg, 2024,11(1):e976. DOI: 10.1002/ams2.976.
|
[5] |
LadhaniHA, YowlerCJ, ClaridgeJA. Burn wound colonization, infection, and sepsis[J]. Surg Infect (Larchmt), 2021,22(1):44-48. DOI: 10.1089/sur.2020.346.
|
[6] |
GuF, HeW, ZhuD, et al. A 10-year retrospective study of methicillin-resistant Staphylococcus aureus from burn wound infection in southeast China from 2013 to 2022[J]. Front Microbiol, 2023,14:1301744. DOI: 10.3389/fmicb.2023.1301744.
|
[7] |
WangY, LiQ, ShuQ, et al. Clinical epidemiology and a novel predicting nomogram of central line associated bloodstream infection in burn patients[J]. Epidemiol Infect, 2023,151:e90. DOI: 10.1017/S0950268823000766.
|
[8] |
JeonK, HanSB, KymD, et al. Central venous catheter tip colonization and associated bloodstream infection in patients with severe burns under routine catheter changing[J]. Am J Infect Control, 2024,52(7):813-818. DOI: 10.1016/j.ajic.2024.02.003.
|
[9] |
MaitzJ, MerlinoJ, RizzoS, et al. Burn wound infections microbiome and novel approaches using therapeutic microorganisms in burn wound infection control[J]. Adv Drug Deliv Rev, 2023,196:114769. DOI: 10.1016/j.addr.2023.114769.
|
[10] |
DeyPK, GalibA, SardarA, et al. Nosocomial infection among burn patients admitted to a tertiary care hospital of Bangladesh: a cross-sectional study[J]. Ann Burns Fire Disasters, 2023,36(3):202-208.
|
[11] |
PalmieriTL. Infection prevention: unique aspects of burn units[J]. Surg Infect (Larchmt), 2019,20(2):111-114. DOI: 10.1089/sur.2018.301.
|
[12] |
罗高兴, 詹日兴, 袁志强, 等. 浅谈烧伤感染的分类与诊断命名[J].中华烧伤与创面修复杂志,2023,39(4):301-304. DOI: 10.3760/cma.j.cn501225-20221206-00528.
|
[13] |
DellingerRP, CarletJM, MasurH, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004,32(3):858-873. DOI: 10.1097/01.ccm.0000117317.18092.e4.
|
[14] |
EvansL, RhodesA, AlhazzaniW, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021,49(11):e1063-e1143. DOI: 10.1097/CCM.0000000000005337.
|
[15] |
BoneRC, BalkRA, CerraFB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest,1992, 101(6):1644-1655. DOI: 10.1378/chest.101.6.1644.
|
[16] |
SingerM, DeutschmanCS, SeymourCW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016,315(8):801-810. DOI: 10.1001/jama.2016.0287.
|
[17] |
中华医学会烧伤外科学分会.中国烧伤年度报告2010-2016[M].2017.
|
[18] |
TanJ, LiN, GongY, et al. Procalcitonin kinetics early after severe burn injury and its value in diagnosis of sepsis[J]. Burns, 2021,47(8):1802-1809. DOI: 10.1016/j.burns.2021.02.024.
|
[19] |
ZhangYJ, GuoZH, MingZG, et al. Meta-analysis of the diagnostic value of serum procalcitonin for burn sepsis in adults[J]. Eur Rev Med Pharmacol Sci, 2023,27(15):7188-7200. DOI: 10.26355/eurrev_202308_33292.
|
[20] |
BarayanD, AbdullahiA, VinaikR, et al. Interleukin-6 blockade, a potential adjunct therapy for post-burn hypermetabolism[J]. FASEB J, 2021,35(5):e21596. DOI: 10.1096/fj.202100388R.
|
[21] |
HagerS, FoldenauerAC, RennekampffHO, et al. Interleukin-6 serum levels correlate with severity of burn injury but not with gender[J]. J Burn Care Res, 2018,39(3):379-386. DOI: 10.1097/BCR.0000000000000604.
|
[22] |
GreenhalghDG, SaffleJR, 4thHolmes JH, et al. American Burn Association consensus conference to define sepsis and infection in burns[J]. J Burn Care Res, 2007,28(6):776-790. DOI: 10.1097/BCR.0b013e3181599bc9.
|
[23] |
ISBI Practice Guidelines Committee, SubcommitteeSteering, SubcommitteeAdvisory. ISBI practice guidelines for burn care[J]. Burns, 2016,42(5):953-1021. DOI: 10.1016/j.burns.2016.05.013.
|
[24] |
GreenhalghDG, HillDM, BurmeisterDM, et al. Surviving Sepsis After Burn Campaign[J]. Burns, 2023,49(7):1487-1524. DOI: 10.1016/j.burns.2023.05.003.
|
[25] |
YinZ, BeiwenW, ZhenzhuM, et al. Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis[J]. Sci Rep, 2022,12(1):20105. DOI: 10.1038/s41598-022-24492-z.
|